GFS
CELG

GYL Financial Synergies’s Celgene Corp CELG Stock Holding History

GYL Financial Synergies’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-7,450
Closed -$477K – 164
2018
Q4 		$477K Buy
+7,450
New +$550K 0.35% 58

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

GYL Financial Synergies's CELG Position: Q1 2019 in Review

GYL Financial Synergies sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 7,450 shares — an estimated $477K sold.

GYL Financial Synergies first reported a position in CELG in Q4 2018 and held it in 1 quarter. The position peaked at $477K in Q4 2018. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

  • GYL Financial Synergies reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
  • GYL Financial Synergies sold 7,450 Celgene Corp shares in Q1 2019, an estimated $477K.
  • GYL Financial Synergies first reported a position in Celgene Corp in Q4 2018 and held it in 1 quarter.
  • GYL Financial Synergies's Celgene Corp position peaked at $477K in Q4 2018.
  • 1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on GYL Financial Synergies's 13F filing for Q1 2019, filed 14 May 2019.